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ORIGINAL ARTICLE
ER stress protein AGR2 precedes and is involved in the
regulation of pancreatic cancer initiation
L Dumartin1, W Alrawashdeh1, SM Trabulo2, TP Radon1, K Steiger3, RM Feakins4, MP di Magliano5, C Heeschen2, I Esposito6,
NR Lemoine1 and T Crnogorac-Jurcevic1
The mechanisms of initiation of pancreatic ductal adenocarcinoma (PDAC) are still largely unknown. In the present study, we
analysed the role of anterior gradient-2 (AGR2) in the earliest stages of pancreatic neoplasia. Immunohistochemical analysis of
chronic pancreatitis (CP) and peritumoral areas in PDAC tissues showed that AGR2 was present in tubular complexes (TC) and early
pancreatic intraepithelial neoplasia (PanINs). Moreover, AGR2 was also found in discrete subpopulations of non-transformed cells
neighbouring these pre-neoplastic lesions. In primary cells derived from human patient-derived xenograft (PDX) model, ﬂow-
cytometry revealed that AGR2 was overexpressed in pancreatic cancer stem cells (CSC) compared with non-stem cancer cells. In
LSL-KrasG12D;Pdx1-Cre (KC) mouse model Agr2 induction preceded the formation of pre-neoplastic lesions and their development
was largely inhibited by Agr2 deletion in engineered LSL-KrasG12D;Pdx1-Cre; Agr2−/− mice. In vitro, AGR2 expression was stimulated
by tunicamycin-induced endoplasmic reticulum (ER) stress in both KRAS wild-type normal pancreas cells, as well as in KRAS mutated
pancreatic cancer cells and was essential for ER homoeostasis. The unfolded protein response proteins GRP78, ATF6 and XBP1s
were found expressed in CP and PDAC peritumoral tissues, but in contrast to AGR2, their expression was switched off during TC and
PanIN formation. Real-time PCR and ELISA analyses showed that ER stress induced a pro-inﬂammatory phenotype in pancreatic
normal, cancer and stellate cells. Moreover, AGR2 expression was inducible by paracrine transfer of ER stress and pro-inﬂammation
between different pancreatic cell types. Our ﬁndings demonstrate that AGR2 induced in ER-stressed and inﬂammatory pre-
neoplastic pancreas is a potential marker of cancer progenitor cells with an important functional role in PDAC initiation.
Oncogene advance online publication, 12 December 2016; doi:10.1038/onc.2016.459
INTRODUCTION
Pancreatic ductal adenocarcinoma (PDAC) remains one of the
most aggressive and incurable of all malignancies and is projected
to become the second leading cause of cancer-related deaths by
2030.1 The main reason for this dismal prognosis is the
asymptomatic nature of the early stages of the disease resulting
in the vast majority of patients to present at an advanced stage of
malignancy. Understanding the mechanisms of PDAC initiation is
therefore essential for the development of preventive measures,
early detection techniques and timely therapeutic intervention.
PDAC and its most common precursor lesions, pancreatic
intraepithelial neoplasias (PanINs), are thought to mainly originate
from tubular complexes (TC) formed in the centroacinar-acinar
compartment through a reprogramming process named acinar-to-
ductal metaplasia or through the proliferation of centroacinar
cells.2 The KRAS gene is found mutated (KRASG12D) almost
ubiquitously in PDAC and PanIN lesions3 and is considered the
key driver oncogene in pancreatic cancer initiation. Preclinical
mouse models expressing oncogenic Kras under the control of
speciﬁc pancreatic promoters (for example Pdx-1, Elas) develop TC,
the full spectrum of PanINs and PDAC.2
There is growing evidence that KRAS-induced carcinogenesis is
promoted by cellular stress like chronic inﬂammation, which plays
a crucial role in tumour initiation and progression. Experimentally
induced inﬂammation has been shown to be critical in oncogenic
Kras-induction of PanINs and PDAC in adult mice and in humans,
chronic pancreatitis (CP) has been identiﬁed as one of the major
risk factors for development of PDAC, and both of these diseases
share the presence of TC and PanINs.4–7
Pancreatic (and other) cancer cells frequently experience
endoplasmic reticulum (ER) stress resulting from the accumulation
of misfolded proteins in the ER due to protein overexpression,
oxidative stress, hypoxia, nutrient deprivation and/or calcium
depletion. Cells adapt to ER stress by activating the unfolded
protein response (UPR) signalling pathway in order to restore
ER homoeostasis, but in prolonged or severe stress conditions,
cellular signalling switches from pro-survival to ER stress-induced
apoptosis.4 UPR has been shown to be constitutively active in
exocrine pancreas due a high demand for protein synthesis and to
be essential for acinar cells homoeostasis.5 However, ER stress can
induce cellular inﬂammation6 and has been related to the
induction of CP.7,8
Anterior gradient 2 (AGR2) is a member of the protein
disulphide isomerase family of ER-resident proteins. As such, it is
involved in maturation of various proteins; through forming
disulphide bonds with mucins, it directly regulates their proces-
sing and secretion. Importantly, AGR2 is induced by ER stress,
mainly through activation of the ATF6 and IRE1 arms of the UPR,9
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and participates in the control of ER homoeostasis; AGR2-silenced
cells display reduced quality control and folding abilities and are
highly sensitive to ER-stress.10
AGR2 is also a pro-oncogenic protein that is expressed in
various cancers, where it can regulate p53 signalling and induce
EGFR ligand amphiregulin to enhance cell survival and spur cancer
cell growth (reviewed in ref. 9). In PDAC, AGR2 is found activated
downstream of mutant KrasG12D (ref. 11) and its important role in
PDAC development was shown using both orthotopic 12 and Kras-
driven pancreatic cancer mouse model with deletion of Smad4, a
tumour suppressor gene frequently lost in the late stage (PanIN-3)
of pancreatic carcinogenesis.13 We showed previously that AGR2 is
found, in addition to primary cancer, circulating tumour cells and
metastatic lesions, to be invariably induced in patients from the
earliest PanIN lesions to PDAC.14 Interestingly, AGR2 has recently
been described as a potential marker of the cellular origin of
oesophageal and cervical cancers.15,16 This has prompted us to
analyse the induction and the role of AGR2 in the earliest stages of
pancreatic neoplasia and to explore its potential connection with
ER stress in PDAC.
Here, we present evidence that in the initial course of PDAC
development AGR2 can be induced in pancreatic cells as a
response to ER stress and/or oncogenic KRAS even before visible
neoplasia; we reveal a critical role for AGR2 in the formation of
KRAS-driven pre-neoplastic lesions, and we demonstrate that
ER stress is associated with the development of a pro-
inﬂammatory microenvironment.
RESULTS
AGR2 is induced in nontransformed, inﬂamed and metaplastic
exocrine pancreas
To examine the induction of AGR2 expression in the early stages
of PDAC development, we performed a detailed immunohisto-
chemical analysis in human CP and in the tissue compartment
adjacent to cancer, both characterized by the presence of pre-
neoplastic lesions (Figure 1; Supplementary Figure S1). While
normal pancreas was largely negative (Figure 1a, ﬁrst panel), AGR2
was found expressed in a similar pattern in peritumoral tissues
and CP. We showed that AGR2 was expressed in all PanINs with
moderate to high-intensity, displaying a cytoplasmic and mem-
branous pattern (Figure 1a and ref. 14). In addition, AGR2 was also
found expressed in TC, as well as in subpopulations of
phenotypically normal-appearing acinar, centroacinar and duc-
tal/terminal ductal cells. These phenotypically normal AGR2-
positive cells were found in the vicinity or in direct contact to
preneoplastic lesions (Figures 1b and c), suggesting that they can
be potential precursors to TC and PanINs. For example,
peritumoral tissues (Figure 1b) mostly show no AGR2 expression,
but AGR2-positive acinar-centroacinar cells were detected in the
periphery of pre-neoplastic AGR2-positive lesions; CP tissues
(Figure 1c) also show no expression, except for AGR2-positive
terminal ducts that were found surrounding TC and PanIN lesions.
Phenotypically normal AGR2-positive cells were also detected in
PDAC cores (Supplementary Figure S1A).
As tumour-initiating cells are thought to display stem cell-like
properties, we explored the expression of AGR2 in pancreatic
cancer stem cells using autoﬂuorescence as a cancer stem cell
(CSC) marker17 for isolation using ﬂow-cytometry (Figure 1d and
Supplementary Figure S2). We showed by western blot that AGR2
protein was overexpressed in pancreatic CSC isolated from two
primary patient-derived cell lines (A6L and 185) when compared
to non-stem cancer cells.
In mice, AGR2 protein was not expressed in pancreata of control
LSL-KrasG12D/+(K) animals (Figure 2a). Analysis of germline Agr2−/−
knock-out mouse pancreas showed that Agr2 deletion does not
appear to morphologically alter normal pancreas development
(Supplementary Figure S3). In LSL-KrasG12D/+;Pdx1-Cre (KC) mouse
model (Figure 2b), Agr2 protein started accumulating in pheno-
typically normal acinar cells in 2 week-old KC mice devoid of any
apparent pancreatic lesions. In pancreata from 4 to 12 week-old
mice, high levels of Agr2 expression were detected in all TC and
PanINs, independently of their grade. We have also analysed the
p48-Cre;R26-rtTa-IRES-EGFP;TetO-KrasG12D (iKras) mouse model18
and observed a similar pattern of expression (representative
images are shown on Supplementary Figure S4). Thus, in Kras-
induced tumourigenesis in mice, Agr2 induction is also an early
event that precedes visible neoplasia. All together, these data
indicate that pre-neoplastic pancreatic lesions may arise from
AGR2-positive progenitor cells.
Loss of AGR2 impairs early stages of Kras-driven pancreatic
transformation
To further conﬁrm early AGR2 induction and assess whether AGR2
is implicated in the formation of pre-neoplastic lesions, we
knocked-out Agr2 in KC transgenic PDAC mouse model to
generate LSL-KrasG12D/+;Pdx1-Cre;Agr2−/− (KCA) mice (Figure 2c).
The KC mouse develops TC and low-grade PanINs in less than
4 weeks after birth; Figure 2d shows representative pancreas
histology of KC and KCA strains at 1 month. We analysed the effect
of Agr2 loss by quantifying cytokeratin 19-positive TC and low-
grade PanINs at that stage (Figure 2e). As shown in Figure 2f, loss
of Agr2 resulted in a signiﬁcant reduction (Po0.001) in both the
number of pre-neoplastic lesions (2.23 ± 1.01 vs 15.89 ± 1.19) and
their foci (1.15 ± 0.49 vs 9.94 ± 0.65) in KCA (n= 13) compared to
KC (n= 18) mouse pancreata, respectively. Moreover, 100% of KC
mice presented lesions in the pancreas at 1 month whereas
460% of KCA mice tissues were histologically normal. Detailed
quantiﬁcation data are presented in Supplementary Table S1.
Taken together, these results demonstrated that Agr2 plays an
important functional role in the development of pre-neoplastic
lesions during Kras-driven tumourigenesis.
AGR2 is an ER-stress response protein
To assess the putative role of ER stress in AGR2 induction in
pancreas, four pancreatic cell lines were treated for 2, 6 or 24 h
with 5 μM tunicamycin, a well-known ER stress inducer
(Figure 3a). We used the KRAS wild-type (wt) immortalized
normal human pancreatic ductal HPDE cells, the KRASH61Q
mutated PDAC cell line T3M4, and two KRASG12D PDAC cell
lines: FA6 and CFPAC1. ER stress induction was conﬁrmed by
real-time PCR analysis of ER stress marker genes XBP1s
(Figure 3a), XBP1, GRP78, CHOP, GADD34 and ATF4
(Supplementary Figure S5). XBP1s appeared to be the most
sensitive marker of tunicamycin-induced ER stress. AGR2 gene
expression was shown to be induced in all tested pancreatic
cell lines after stress induction. Western blot conﬁrmed
the induction of AGR2 protein in all cell lines after 24 h
(Figure 3a).
In order to test if AGR2 is functionally involved in ER stress
response, we silenced AGR2 in FA6 and CFPAC1 cells that
express AGR2 endogenously (Figure 3b). 72 h after silencing of
AGR2, real-time PCR showed a signiﬁcant overexpression of
XBP1s (bottom panels) and previously tested ER stress markers
(data not shown). AGR2 is therefore an ER stress marker in
pancreatic cells and is functionally involved in maintenance of
ER homoeostasis.
ER stress and UPR switch in early stages of pancreatic neoplasia
CP is thought to be associated with an abnormal response to ER
stress.7 To assess the potential role of ER stress response in PDAC
initiation, we analysed the expression of ER stress markers and
UPR regulator proteins XBP1s, ATF6 and GRP78 in both CP and
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Figure 1. AGR2 expression in human pancreas. (a) Immunohistochemical analysis of AGR2 expression in chronic pancreatitis (CP) and PDAC
peritumoural tissues. AGR2 protein expression was absent in most of the pancreas (top left) but induced in early PanINs (top right) and tubular
complexes, CT (central left), as well as focally induced in phenotypically normal acinar (central right), centroacinar cells (bottom left) and duct/
terminal duct (bottom right). (b) AGR2 expression in representative peritumoural area. Low magniﬁcation of a pancreas tissue (top left)
showing area with no AGR2 expression (top right), AGR2 induction in acinar cells (central panels) and AGR2-expressing putative pre-neoplastic
lesions, TC (bottom left) and PanIN (bottom right). (c) AGR2 expression in representative CP tissue. Low magniﬁcation of a pancreas (top left)
showing area with no AGR2 expression (top right), moderate AGR2 induction in small and terminal ducts (central left) and strong AGR2
expression in TC and PanINs (central right and bottom panels). Scale bars, 50 μm. (d) FACS sorted autoﬂuorescent (Fluo+) and non-
autoﬂuorescent (Fluo-) populations of two different PDX-derived primary cell lines (A6L and 185, top panels) were analysed for AGR2
expression by Western blot (bottom left). Densitometry analysis is shown on the right panel.
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peritumoural tissues on the same TMAs used to explore AGR2
expression. The three UPR proteins presented similar expression
pattern in peritumoral tissues (data not shown) and CP;
representative CP images are shown in Figure 4a. XBP1s showed
nuclear expression in some acinar and individual ductal cells. In
TC, XBP1s showed low to high cytoplasmic expression but PanIN
lesions were predominantly negative. ATF6 expression was
moderate to strong in normal acinar cells and weak to absent in
normal ducts, TC and PanINs. GRP78 expression was hetero-
geneous in normal acinar cells with weak to strong intensity and
was weakly positive or lost in TC and PanINs. Therefore, we
conﬁrmed that ER stress is activated in CP and peritumoral regions
and revealed that the development of pancreatic pre-neoplastic
lesions is associated with the loss of canonical ER stress response
proteins. As illustrated in Figure 4b, this UPR switch is
characterized by an inverse correlation in the expression of
classical UPR proteins and AGR2 during early pre-cancerous
lesions development.
ER stress activates pancreatic stellate cells and links AGR2 to a pro-
inﬂammatory phenotype
Pancreatic stellate cells have been shown to play a critical role in
CP and PDAC development which is associated with their
acquisition of an inﬂammatory phenotype.19 To further conﬁrm
the role of ER stress in PDAC initiation, we tested in vitro the effect
of ER stress on PS1 pancreatic stellate cells. PS1 cells were treated
with 1 μM of tunicamycin for 30 min to 6 h. Real-time PCR analysis
of XBP1s (Figure 5a, top left panel) and a panel of ER stress markers
(Supplementary Figure S6) conﬁrmed the induction of ER stress in
PS1 cells. ER stress induction was associated with a signiﬁcant
gene overexpression of the pro-inﬂammatory cytokine IL6 and a
signiﬁcant increase in IL6 protein secretion in culture supernatants
as measured by ELISA (Figure 5a, top right panels). As ER stress has
been shown to be transmissible by cell-to-cell communication,20
PS1 cells were then incubated for 6 h with supernatants from
ER-stressed or control FA6 and CFPAC1 cell lines (bottom panels).
Figure 2. AGR2 loss impairs development of pancreatic pre-neoplastic lesions. (a) The absence of AGR2 expression in control LSL-KrasG12D/+
(K) mice pancreas. (b) AGR2 expression in LSL-KrasG12D/+;Pdx1-Cre (KC) mouse model. AGR2 expression in acinar cells in 2 weeks-old KC mice
(top left) and in tubular complexes (top right), low-grade and high-grade PanINs (left and right bottom panels, respectively) in 4–12 weeks old
mice pancreas. Scale bars, 50 μm. (c) Genetic make up to activate oncogenic Kras in the pancreas using Cre-loxP recombination system and
subsequent crossing with the Agr2 knock-out mouse model. (d) Representative images of H&E staining of 1 month-old KC and KCA mice
pancreas. (e) Cytokeratin 19 (CK19) staining of tubular complexes (left) and early PanINs (central and right panels) in 1 month-old KC mice.
Scale bars, 50 μm. (f) Quantiﬁcation of the numbers of pre-neoplastic lesions and their foci in KC (n= 13) and KCA (n= 18) mice groups.
***Po0.001.
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We observed a signiﬁcant induction of XBP1s (Figure 5a, bottom
left) and other ER stress markers (Supplementary Figure S6) in
PS1 cells treated with ER stress-conditioned media compared to
controls. Moreover, ER stress induction was again coupled to an
induction of IL6 gene (Figure 5a, bottom right). Therefore,
ER-stressed pancreatic stellate cells adopt a pro-inﬂammatory
phenotype that can be initiated in a cell-autonomous or paracrine
manner.
Tunicamycin treatment of HPDE cells led to high and signiﬁcant
increase of AGR2 expression and moderate, but signiﬁcant, IL6
expression (Figure 5b, top). HPDE cells treated with conditioned
media from ER-stressed PDAC or PS1 cells (central and bottom
panels) also experienced ER stress and showed a signiﬁcant
induction of AGR2 and IL6 expression. AGR2 expression and
inﬂammation can thus be induced in pancreatic cells by
transmission of ER stress from both cancer and stromal cells.
DISCUSSION
In this study we demonstrate the importance of AGR2 in the
initiation of PDAC. Through combined observations from both
human tissues and mouse genetic models, we showed that AGR2
is a marker of pancreatic pre-neoplasia. While we previously
showed that AGR2 is induced from the earliest PanINs,14 here, we
revealed that AGR2 induction precedes PanIN formation as it is
also expressed in their putative precursor lesions, tubular
complexes. Interestingly, in the close vicinity of these lesions we
found subpopulations of phenotypically normal-appearing AGR2-
expressing cells that could represent PDAC-initiating cells; this is
analogous to the population of AGR2-expressing cells identiﬁed as
initiating cervical and oesophageal cancers.15,16 This hypothesis is
reinforced by the observation of a similar expression pattern in
murine models, which are amenable to kinetic analysis, where
AGR2 was absent in normal mouse pancreas but was expressed in
the pancreas of KC mice before any noticeable neoplasia. This
early induction further implicates AGR2 as a putative downstream
target of mutated KrasG12Dsignalling, as recently reported.11
Similarly in the Kras;DicerHet mice, it was shown that the mutated
Kras may compromise acinar identity prior the induction of ductal
genes and morphology, and that it contributes to the upregula-
tion of several genes/pathways even before acinar-to-ductal
metaplasia occurs; importantly, Agr2 was one of these genes.21
This not only further supports our mouse data with loss of Agr2
impairing PanIN development in KC mice, but also mimics our
immunohistochemistry data in human tissues.
As we ﬁnd AGR2 is later expressed in all Kras-induced pre-
neoplastic lesions and AGR2 knock-out largely inhibited their
development, this suggests that pre-neoplastic lesions may
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Figure 3. AGR2 is induced by ER stress in pancreatic cells and regulates ER homoeostasis. (a) Real-time PCR analysis showed XBP1s and AGR2
gene overexpression in HPDE (KRAS wt), T3M4 (KRASH61Q), and FA6 and CFPAC1 (both KRASG12D) pancreatic cell lines treated with 5 μM of
tunicamycin (Tm) for 2, 6 or 24 h. S16 was used as a control gene. Western blot analysis (right panels) showed AGR2 protein accumulation after
24 h tunicamycin-treatment; tubulin protein was used as a loading control. (b) 72 h after siRNA silencing of AGR2 in CFPAC1 and FA6 cells
(top), overexpression of XBP1s gene was observed by real-time PCR (bottom panels). *Po0.05; **Po0.01.
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originate from AGR2-positive precursors observed in nontrans-
formed pancreas. AGR2 was found induced in different cell types,
including acinar, centroacinar cells and terminal ducts, which is in
agreement with the multiple potential cellular origin proposed for
the development of PDAC.22–28
We analysed the role of AGR2 in vivo using the prenatal
KC model crossed with the germ-line Agr2 knock-out model. While
it was shown previously that heterozygosity for Agr2 associated
with Smad4 deletion (a late event in PDAC development) could
delay PanIN development,13 here we demonstrate the importance
of Agr2 in the initiation of Kras-driven tumourigenesis early and
independently of any late stage mutations. Of note, as Agr2 knock-
out mice tend to develop intestinal complications,13 we only
conducted a short term in vivo experiment to avoid any extra-
pancreatic inﬂuence. The use of an inducible murine Agr2 knock-
out model and mutant KrasG12D, in a spatial and temporal manner,
would permit a more precise analysis of AGR2 functional role in
the initiation of PDAC.29 However, such a model was not available
at the time we were performing our experiments.
AGR2 was previously shown to regulate the proliferation of
stem cells and progenitors and their differentiation into multiple
cell lineages in mouse stomach 30 and to be important for the self-
renewal ability of CSC in head and neck squamous cell
carcinoma.31 Here, we revealed that AGR2 is also overexpressed
at the protein level in pancreatic CSC compared with non-stem
cancer cells. Taken together, our data indicate that AGR2 plays an
important role in PDAC initiation and development, potentially by
regulating the maintenance of stemness and progenitor cell
differentiation.
The great secretory capacity of the exocrine pancreas and its
highly developed ER system have led to the hypothesis that ER
stress might underlie pancreatic inﬂammation.32,33 Several known
risk factors for pancreatic cancer, such as chronic inﬂammation,
obesity, diabetes, smoking, etc. are all associated with ER stress
Figure 4. Downregulation of UPR proteins expression during PDAC initiation. (a) Immunohistochemical analysis of XBP1s, ATF6 and GRP78
proteins in human chronic pancreatitis. Scale bars, 50 μm. (b) Schematic representation of the UPR switch during formation of pancreatic pre-
neoplastic lesions. TC, tubular complexes; PanIN, pancreatic intraepithelial neoplasia.
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induction8,34–37 (Figure 6). Interestingly, we show here that AGR2
can be induced in response to ER stress in vitro in pancreatic cells
independently of their Kras status and that AGR2 and ER stress
were invariably activated in vivo in CP and peritumoural tissues. It
is therefore highly likely that, in vivo, ER stress-induction of AGR2
can occur independently, and even before, oncogenic Kras
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Figure 5. ER-stressed pancreatic cells adopt a pro-inﬂammatory phenotype. (a) ER stress induction analysis in PS1 human pancreatic stellate
cells. PS1 cells were treated with 1 μM tunicamycin or vehicle for the indicated times (top panels). XBP1s and IL6 gene expression was analysed
by real-time PCR and IL6 protein levels by ELISA analysis of culture supernatants (right panel). PS1 cells were treated with conditioned media
from ER-stressed or control pancreatic cancer cells and XBP1s and IL6 gene expression analysed by real-time PCR (bottom panels). (b) ER stress
induction analysis in human normal pancreatic HPDE cells after treatment with 5 μM Tm (top panels), with conditioned media from
ER-stressed or control pancreatic cancer cells (central panels), or from ER-stressed or control PS1 pancreatic stellate cells (bottom panels).
XBP1s, AGR2 and IL6 gene expression was analysed by real-time PCR. Ctrl, control; CM, ER stress-conditioned medium; PC, pancreatic cancer
cells; Tm, Tunicamycin. *Po0.05; **Po0.01; ***Po0.001.
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mutation in the PDAC initiation model. This has recently been
demonstrated by Kong et al38 where, after caerulein-induced
pancreatitis, amongst other genes, a ‘wave’ of Agr2 expression was
seen – a high increase during regeneration and decrease during
reﬁnement phases in wt mice; in Kras-mutated mice after
caerulein challenge, Agr2 upregulation was additionally seen
during inﬂammatory phase, and was pronounced during the
reﬁnement phase, which now does not progress to resolution, but
rather to acinar-to-ductal metaplasia, PanIN and PDAC develop-
ment. Therefore, it is likely that by enhancing ER folding capacity,
AGR2 allows the pre-cancerous cells to cope with an increased
protein demand both before and or/after oncogenic mutations.
The ﬁne-tuning and the correlation of AGR2 expression and the
levels of KRAS activity in human system however, still remain to be
further established.
Interestingly, in contrast to the induction of AGR2, the
expression of three UPR proteins XBP1s, ATF6 and GRP78,
essential for cellular proteostasis, was lost during the development
of premalignant lesions (the ATF4/CHOP UPR branch of the
ER stress could not be assessed due to suboptimal quality of IHC
data). This early switch might be essential for cancer initiating cells
to survive ER stress whilst avoiding UPR-related apoptosis. The
antiapoptotic role of AGR2, at least in vitro, was recently
demonstrated through the direct association of its homodimer
with GRP78.39
The demonstrated in vivo dependency on AGR2 for the
formation of premalignant lesions is likely due to its important
role in cellular proteostasis during cell transformation, and
induction of AGR2 in pancreas might therefore be a marker of
pathologic response to proteotoxic stress.
Finally, we also revealed that ER stress-induction of AGR2 is
associated with the acquisition of a pro-inﬂammatory phenotype
and that ER stress could be the mediator of an intercellular
communication between both epithelial and stromal cells
(Figure 6) as shown here for pancreatic stellate cells and
previously for macrophages.20 The pronounced induction of
AGR2 by the conditioned media of ER stressed cells could
potentially be explained by the deregulation of a large panel of
secreted proteins (in addition to IL6), some of which could
represent potential paracrine candidates. To this end we have
tested if IL6 could exert such an effect, however both siRNA
silencing of IL6 or the treatment of cells with recombinant IL6
protein, did not affect AGR2 expression levels (data not shown).
It is thus plausible that other paracrine mediators, including
inﬂammatory mediators such as reactive oxygen species (ROS), are
involved in the intercellular communication between ER stress and
AGR2 expression; however, this hypothesis remains to be
addressed further.
Based on the presented ﬁndings, it is tempting to speculate that
the crosstalk between the stressed epithelial and stromal cells
might also contribute in vivo to the initiation and progression of
PDAC by stimulating the development of an inﬂammatory
environment as well as promoting ﬁeld cancerization.
Figure 6. Schematic illustration of AGR2 role and induction in pancreatic cancer initiation. Different conditions and environmental factors
(pancreatitis, obesity, smoking, alcohol, pathogens and reactive oxygen species) can cause ER stress in the pancreas. ER stress induces the
expression of UPR proteins to restore ER homoeostasis. When UPR is not sufﬁcient to restore homoeostasis in presence of a prolonged or
chronic ER stress it can result in inﬂammatory diseases such as chronic pancreatitis. Paracrine transfer of ER stress between pancreatic cells
might further stimulate the development of a pro-inﬂammatory environment. Occurrence of KRAS mutation in such environment is a key
driver event for pancreatic cancer initiation. AGR2 expression is both induced by ER stress and KRAS mutation and is critical for
ER homoeostasis and the early stages of pancreatic carcinogenesis. While AGR2 expression is induced through all the initiating stages of
PDAC, UPR proteins appeared to be downregulated during the formation of premalignant lesions. This loss might potentially be directly
caused by the occurrence of KRAS oncogenic mutation (also stimulating AGR2 expression) and result in protection of cancer-initiating cells
from UPR-related apoptosis. Dependency on AGR2 at that stage may therefore reﬂect its important role in cellular proteostasis during
neoplasia.
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In summary, our study sheds new light on PDAC initiation and
development and reveals the induction of the pro-oncogenic
AGR2 protein in pancreas before manifested neoplasia. Acquisi-
tion of resistance against UPR-induced cell death during chronic
ER stress conditions might be an early and widespread mechan-
ism in PDAC development, and targeting AGR2 could be a
promising strategy to reverse this acquired survival advantage and
increase cancer cell vulnerability. In this way, targeting ER stress
resistance in combination with ER stress-inducing drugs, like
IPI-504 40 or bortezomib,41,42 represents a promising preventive or
therapeutic strategy against aggressive KRAS-driven tumours like
pancreatic cancer.
MATERIALS AND METHODS
Cells and tissues
The immortalized human pancreatic duct epithelial cell line HPDE was
obtained from Dr Ming-Sound Tsao (University of Toronto); the immorta-
lized normal human pancreatic stellate cell line PS1 was obtained from
Prof. Hemant Kocher (Barts Cancer Institute, London); both cell lines were
grown as described previously.43,44 The remaining cell lines were obtained
from Cancer Research UK Cell Services and cultured in Dulbecco's Modiﬁed
Eagle Medium, DMEM, (Invitrogen, Paisley, UK) supplemented with 10%
heat-inactivated fetal calf serum (Autogen Bioclear, Wiltshire, UK). The
identity of cell lines was veriﬁed by STR proﬁling. PDAC patient-derived
xenografts (PDXs) (referred as anonymous patient numbers: 185 and A6L)
were processed as previously described.45 Human tissue microarrays
(TMAs) comprising acinar-to-ductal metaplasia, TC, PanIN, CP and PDAC
lesions used for immunohistochemcal analyses were constructed as
described previously.2
RNA extraction and semi-quantitative real-time PCR
Total RNA was extracted using RNAqueous RNA extraction kit (Ambion,
Warrington, UK). complementaryDNA (cDNA) was synthesized from 1 μg of
total RNA with Quantitect Reverse Transcription kit (Qiagen, Crawley, UK).
Real-time PCR was performed using a 7500 Real Time PCR System (Applied
Biosystems, Warrington, UK) using SYBR Green dye (Qiagen). Primer
sequences are listed in Supplementary Table S2. All samples were analysed
in three independent experiments. Relative expression changes were
presented after normalization to the human ribosomal S16 gene.
Primers and real-time PCR for pluripotency genes (Nanog, Klf4, Sox2,
Oct3/4 and Nodal) have been described in ref. 17
Gene silencing
Cells were seeded at 2 × 105 cells per well in a 6-well plate and transfected
with 50 nM of siGENOME ON-TARGETplus SMARTpool siRNA speciﬁc for
human AGR2 or siGENOME Non-Targeting siRNA pool #2 (Dharmacon,
Chicago, USA) using INTERFERin (PeqLab, Fareham, UK) according to
manufacturer’s instructions.
Flow cytometry and cell sorting
Cells were harvested by trypsinisation and resuspended in PBS; 3% FBS
(v/v); 1 mM EDTA before sorting with a BD FACSAria II Cell sorter (BD
Biosciences, Oxford, UK). Autoﬂuorescent cells were excited with a 488 nm
blue laser and selected as the intersection with ﬁlters 530/30 and 585/42.
Some non-autoﬂuorescent cells are lost during sorting due to the gate
settings that maintain an appropriate distance between autoﬂuorescent
and non-autoﬂuorescent cells. However, such settings are required to
ensure high purity. DAPI staining was used for exclusion of dead cells.
Western blotting
Cell lysis was performed using NP40 buffer (1% NP40, 50 mM Tris pH7.4,
150 mM NaCl) with protease inhibitors (Roche Diagnostics, West Sussex,
UK). 25 μg of protein lysate were analysed by SDS–polyacrylamide gel
electrophoresis (SDS–PAGE), as previously described.46 Primary antibodies
used were rabbit anti-AGR2 1:250 (Novus Biologicals, Cambridge, UK) and
anti-tubulin 1:500 (Abcam, Cambridge, UK).
Immunohistochemistry
Immunostaining was performed on 4 μm-thick parafﬁn sections using
rabbit anti-AGR2 antibody (Abcam, 1:30), anti-XBP1s (Monoclonal Anti-
bodies Unit, CNIO, Madrid, Spain 1:100), anti-ATF6 (Abcam, 1:8000), anti-
GRP78 (Cell Signalling Technology, Hitchin, UK, 1:200) with DABMap kit,
following protocols for the Ventana Discovery System (Illkirch, France).
Counterstaining was performed with haematoxylin.
Endoplasmic reticulum stress assays
Cells were incubated with 1 or 5 μM tunicamycin (Sigma-Aldrich,
Gillingham, Dorset, UK) in complete media for 2, 6 or 24 h. To obtain
ER stress-conditioned medium, tumour cells were cultured in 5 μM
tunicamycin or vehicle (100% DMSO) for 2 h. Cells were washed twice
with PBS and then incubated in fresh medium for 16 h. Conditioned
medium was centrifuged for 10 min at 2,000 g and then passed through
a 0.22 μm ﬁlter (EMD Millipore, Hertfordshire, UK).
Mouse experiments
LSL-KrasG12D/+ (K) and Pdx1-Cre (C) mice provided by Prof. David Tuveson
(Cold Spring Harbor Laboratory) were interbred to generate LSL-KrasG12D/+;
Pdx1-Cre (KC) mice. In the KC model, the expression of activated Kras is
targeted to the mouse pancreas using a conditional LSL-KrasG12D/+ allele
activated by Cre-mediated recombination, with Cre under the control of
the pancreatic and duodenal homeobox1 promoter (Pdx1). Germline
Agr2−/− mice on a C57Bl/6 background provided by Prof. David Erle
(University of California, San Francisco) were interbred with KC mice to
generate LSL-KrasG12D/+;Pdx1-Cre;Agr2−/− (KCA) mouse strain. Wild-type (wt)
mice were purchased from Charles River Laboratory. For the quantiﬁcation
of pancreatic lesions, haematoxylin and eosin (H&E) or CK19 stained slides
were analysed after scanning using a Pannoramic 250 High Throughput
Scanner (3Dhistech, Budapest, Hungary). All procedures were approved by
the QMUL animal ethics committee and were executed in accordance with
UK Home Ofﬁce regulations.
Statistical analysis
The statistical analysis was performed with the two-tailed paired Student's
t-test using GraphPad Prism software; a P value of o0.05 was chosen as
statistically signiﬁcant. Column bar graphs show mean and s.e.m. of each
data set.
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intraepithelial neoplasia.
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